From Vapes to Victory: Empowering Teens to Overcome Vaping

Needs Statement

Many pediatricians do not understand the evolving vaping landscape, effective counseling techniques for adolescents, and evidence-based approaches to treat nicotine addiction in teens, which hinder their ability to address vaping-related issues comprehensively during adolescent visits. There is also a gap in pediatricians’ ability to effectively counsel adolescents about vaping, which includes providing focused messaging to prevent vaping initiation, counseling current users, and treating nicotine addiction. Many lack the skills to engage in empathetic, evidence-based conversations and interventions tailored to adolescents' unique needs and challenges. Even with the correct information, pediatricians may not apply this knowledge and skill consistently, due to various barriers or lack of resources. They may inadequately address vaping during adolescent visits, struggle to engage in effective counseling conversations, or fail to implement evidence-based interventions for vaping prevention and nicotine addiction treatment, leaving a gap between knowledge and practical application.
This interactive activity aims to comprehensively address the educational needs that underlie the professional practice gaps in dealing with adolescent vaping. Throughout the activity, interactive case studies provide opportunities for hands-on learning. Pediatricians can practice applying the knowledge and skills presented in the activity to realistic situations, enhancing their competence in real-world practice. The activity includes access to readily available resources, including patient handouts, referral networks, and support materials. This empowers pediatricians to implement what they have learned effectively in their clinical settings, ultimately contributing to better outcomes for their patients and helping curb the vaping epidemic among teenagers.


Case Presentations and Interactive Module


Evaluation by questionnaire will address program content, presentation, and possible bias.

Target Audience

Physicians and advanced practice providers who care for adolescent patients in the state of Texas.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Apply the "Ask, Counsel, Treat" method to address youth e-cigarette use.
  • Implement the use of current resonating messaging with teens in order to counsel adolescents who are not using e-cigarettes.
  • Formulate a plan for an adolescent patient who is not ready to quit using e-cigarettes.
  • Develop a plan for cessation and treatment of nicotine addiction in an adolescent patient who is ready to quit.
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Participation
Course opens: 
Course expires: 


April 1, 2024 through April 30, 2026. Original release date: April 1, 2024.


This activity is designed for use by healthcare professionals for educational purposes only. Information and opinion offered by the contributors represent their viewpoints. Conclusions drawn by the participant should be derived from careful consideration of all available scientific information. Prescription information and use of medical devices should be undertaken only after confirmation of information by consulting the FDA-approved uses and information.

Baylor College of Medicine makes every effort to have accurate information presented, no warranty, expressed or implied, is offered. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Links are provided to other Internet sites solely for the convenience of users. Once you link to another site, you are subject to the site's terms and conditions of use including copyright and licensing restrictions.


Some drugs/devices identified during this activity may have United States Food and Drug Administration (FDA) clearance for specific purposes only or for use in restricted research settings. The FDA has stated that it is the responsibility of the individual physician to determine the FDA status of each drug or device that he/she wishes to use in clinical practice and to use the products in compliance with applicable law.

Baylor College of Medicine requires that all faculty/presenters disclose an unlabeled use or investigational use of pharmaceutical and medical device products, and provide adequate scientific and clinical justification for such use.  Physicians are urged to fully review all the available data on products or procedures before using them to treat patients.


Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.  BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In  accordance  with  the  ACCME  Standards for  Commercial Support, BCM has  implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME’s validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions.  If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly. 

All of the relevant financial relationships listed for these individuals have been mitigated.

Glenroy Bridges, Planning Committee Member
Senior Instructional Designer, Leadership and Administration
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Sherita Love, Ph.D., M.Ed., Planning Committee Member
Assistant Professor, Department of Education and Innovative Technology
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Lindy McGee, M.D., Activity Director, Planning Committee Member, Presenter
Assistant Professor of Pediatrics
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Participation
Please login or register to take this course.